Online first
Review paper
Published online: 2024-09-03
The today and tomorrow of (almost) each itch
1, 1, 2
DOI: 10.5603/fd.100944
Abstract
Itch is an unpleasant sensation on the skin that causes the desire to scratch. Its aetiology can be defined by various categories such as cause, period of occurrence, location, and the presence or absence of skin disease in a given area. This burdensome symptom experience can even be compared to chronic pain in terms of quality-of-life-impairment and is particularly common among older people. This article discusses the neural pathways that cause itch, the important but clinically challenging role of histamine, and some of the mechanisms involved in the itch-scratch cycle, such as some quite novel discoveries regarding the contributions of the gastrin-releasing peptide (GRP)/ gastrin-releasing peptide receptor (GRPR) axis, transient receptor potential (TRP) channels, and Janus kinase. Pruritus may be associated with various types of diseases affecting the maternal-foetal relationship, skin, cholestasis, renal system or mental health. Some new therapeutic options include drugs that affect opioid receptors, neurokinin 1 receptor (NK-1R) antagonists, Janus kinase inhibitors, and biologics made by combining antibodies against different types of interleukins associated with the itch sensation. Nevertheless, finding an effective form of therapy for patients with various underlying conditions remains a challenge and is the subject of ongoing clinical research.
Keywords: itchpruritusitch-scratch cycleprurireceptorneuropathic itchGRP/GRPR axisTRP channels
References
- Cevikbas F, Lerner EA. Physiology and pathophysiology of itch. Physiol Rev. 2020; 100(3): 945–982.
- Roh YS, Choi J, Sutaria N, et al. Itch: Epidemiology, clinical presentation, and diagnostic workup. J Am Acad Dermatol. 2022; 86(1): 1–14.
- Villa-Arango AM, Velásquez-Lopera MM, Cardona R. Prurito crónico [Chronic pruritus]. Rev Alerg Mex. 2019; 66(1): 85–98.
- Satoh T, Yokozeki H, Murota H, et al. 2020 guidelines for the diagnosis and treatment of cutaneous pruritus. J Dermatol. 2021; 48(9): e399–e413.
- Balak DMW, Kemperman PM, Thio HB. Chronische jeuk [Chronic itch]. Ned Tijdschr Geneeskd. 2021; 165: D5199.
- Ständer S, Pereira M, Berger T, et al. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch. 2020; 5(4): e42.
- Ständer S. Classification of Itch. Curr Probl Dermatol. 2016; 50: 1–4.
- Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol. 2007; 87(4): 291–294.
- Jafferany M, Davari ME. Itch and psyche: psychiatric aspects of pruritus. Int J Dermatol. 2019; 58(1): 3–23.
- Beck TC, Wilson EM, Wilkes E, et al. Kappa opioid agonists in the treatment of itch: just scratching the surface? Itch (Phila). 2023; 8(4).
- Stefaniak AA, Pereira MP, Zeidler C, et al. Pruritus in pregnancy. Am J Clin Dermatol. 2022; 23(2): 231–246.
- Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014; 134(6): 1527–1534.
- Dalgard FJ, Svensson Å, Halvorsen JA, et al. Itch and mental health in dermatological patients across europe: a cross-sectional study in 13 countries. J Invest Dermatol. 2020; 140(3): 568–573.
- Navarro-Triviño FJ. Pruritus in dermatology: Part 2 — diseases and their treatment. Actas Dermosifiliogr. 2023; 114(7): 613–626.
- Martins MS, Almeida IF, Cruz MT, et al. Chronic pruritus: from pathophysiology to drug design. Biochem Pharmacol. 2023; 212: 115568.
- Kini SP, DeLong LK, Veledar E, et al. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol. 2011; 147(10): 1153–1156.
- Wang F, Kim BS. Itch: a paradigm of neuroimmune crosstalk. Immunity. 2020; 52(5): 753–766.
- Chen ZF. A neuropeptide code for itch. Nat Rev Neurosci. 2021; 22(12): 758–776.
- Weber HC. Gastrointestinal peptides and itch sensation. Curr Opin Endocrinol Diabetes Obes. 2015; 22(1): 29–33.
- Davidson S, Giesler GJ. The multiple pathways for itch and their interactions with pain. Trends Neurosci. 2010; 33(12): 550–558.
- Prosapio JG, Sankar P, Jialal I. Physiology, Gastrin. [Updated 2023 Apr 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK534822/ (30.05.2024).
- Symbol report for GRP. https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4605 (15.02.2024).
- Peng S, Zhan Y, Zhang D, et al. Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy. Proc Natl Acad Sci U S A. 2023; 120(6): e2216230120.
- Inagaki N, Nagao M, Igeta K, et al. Scratching behavior in various strains of mice. Skin Pharmacol Appl Skin Physiol. 2001; 14(2): 87–96.
- Mahmoud O, Soares GB, Yosipovitch G. Transient receptor potential channels and itch. Int J Mol Sci. 2022; 24(1).
- Zhang M, Ma Y, Ye X, et al. TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Signal Transduct Target Ther. 2023; 8(1): 261.
- Shirolkar P, Mishra SK. Role of TRP ion channels in pruritus. Neurosci Lett. 2022; 768: 136379.
- Welz-Kubiak K, Reszke R, Szepietowski JC. Pruritus as a sign of systemic disease. Clin Dermatol. 2019; 37(6): 644–656.
- Wojtowicz-Prus E, Kiliś-Pstrusińska K, Reich A, et al. Chronic kidney disease-associated pruritus in children. Acta Derm Venereol. 2016; 96(7): 938–942.
- Mistik S, Utas S, Ferahbas A, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol. 2006; 20(6): 672–678.
- Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease. Cochrane Database Syst Rev. 2020; 12(12): CD011393.
- Vander Does A, Levy C, Yosipovitch G. Cholestatic itch: our current understanding of pathophysiology and treatments. Am J Clin Dermatol. 2022; 23(5): 647–659.
- Yu H, Zhao T, Liu S, et al. MRGPRX4 is a bile acid receptor for human cholestatic itch. Elife. 2019; 8: e48431.
- Mittal A. Cholestatic itch management. Curr Probl Dermatol. 2016; 50: 142–148.
- Selim R, Ahn J. Pruritus in chronic liver disease. Clin Liver Dis. 2023; 27(1): 47–55.
- Szczęch J, Wiatrowski A, Hirnle L, et al. Prevalence and relevance of pruritus in pregnancy. Biomed Res Int. 2017; 2017: 4238139.
- Lambert J. Itch in pregnancy management. Curr Probl Dermatol. 2016; 50: 164–172.
- Ambros-Rudolph CM. Dermatoses of pregnancy — clues to diagnosis, fetal risk and therapy. Ann Dermatol. 2011; 23(3): 265–275.
- Kurien G, Carlson K, Badri T. Dermatoses of Pregnancy. [Updated 2024 Jan 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK430864/ (30.05.2024).
- Chouk C, Litaiem N. Pruritic urticarial papules and plaques of pregnancy. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK539700/ (30.05.2024).
- Zhou FF, Cheng K, Boozalis EC, et al. Polymorphic eruption of pregnancy associated with bullae formation. JAAD Case Rep. 2023; 42: 62–65.
- Dominguez-Serrano AJ, Quiroga-Garza A, Jacobo-Baca G, et al. Polymorphic eruption of pregnancy in Mexico. Int J Dermatol. 2019; 58(3): 259–262.
- Al-Saif F, Elisa A, Al-Homidy A, et al. Retrospective analysis of pemphigoid gestationis in 32 Saudi patients — clinicopathological features and a literature review. J Reprod Immunol. 2016; 116: 42–45.
- Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018; 231: 180–187.
- Golpanian RS, Kim HS, Yosipovitch G. Effects of stress on itch. Clin Ther. 2020; 42(5): 745–756.
- Kiupel S, Kupfer J, Kottlors S, et al. Is stress related to itch in German students? Results of an online survey. Front Med (Lausanne). 2023; 10: 1104110.
- Stewart TJ, Schut C, Whitfeld M, et al. Cross-sectional study of psychological stress and skin symptoms in Australian university students. Australas J Dermatol. 2018; 59(1): e82–e84.
- Pacan P, Grzesiak M, Reich A, et al. Is pruritus in depression a rare phenomenon? Acta Derm Venereol. 2009; 89(1): 109–110.
- Reszke R, Krajewski P, Szepietowski JC. Emerging therapeutic options for chronic pruritus. Am J Clin Dermatol. 2020; 21(5): 601–618.
- Welsh SE, Xiao C, Kaden AR, et al. Neurokinin-1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial. J Eur Acad Dermatol Venereol. 2021; 35(5): e338–e340.
- Inan S, Torres-Huerta A, Jensen LE, et al. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. Eur J Pharmacol. 2019; 864: 172702.
- Han Y, Woo YuRi, Cho SH, et al. Itch and Janus kinase inhibitors. Acta Derm Venereol. 2023; 103: adv00869.
